189 related articles for article (PubMed ID: 21610323)
21. PcG proteins, DNA methylation, and gene repression by chromatin looping.
Tiwari VK; McGarvey KM; Licchesi JD; Ohm JE; Herman JG; Schübeler D; Baylin SB
PLoS Biol; 2008 Dec; 6(12):2911-27. PubMed ID: 19053175
[TBL] [Abstract][Full Text] [Related]
22. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression.
Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M
J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536
[TBL] [Abstract][Full Text] [Related]
23. DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs.
So AY; Jung JW; Lee S; Kim HS; Kang KS
PLoS One; 2011 May; 6(5):e19503. PubMed ID: 21572997
[TBL] [Abstract][Full Text] [Related]
24. Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells.
Mochizuki-Kashio M; Mishima Y; Miyagi S; Negishi M; Saraya A; Konuma T; Shinga J; Koseki H; Iwama A
Blood; 2011 Dec; 118(25):6553-61. PubMed ID: 22042701
[TBL] [Abstract][Full Text] [Related]
25. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML.
Paul TA; Bies J; Small D; Wolff L
Blood; 2010 Apr; 115(15):3098-108. PubMed ID: 20190193
[TBL] [Abstract][Full Text] [Related]
26. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
[TBL] [Abstract][Full Text] [Related]
27. Expression profile of the polycomb group protein enhancer of Zeste homologue 2 and its prognostic relevance in renal cell carcinoma.
Hinz S; Weikert S; Magheli A; Hoffmann M; Engers R; Miller K; Kempkensteffen C
J Urol; 2009 Dec; 182(6):2920-5. PubMed ID: 19846140
[TBL] [Abstract][Full Text] [Related]
28. A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner.
Attwooll C; Oddi S; Cartwright P; Prosperini E; Agger K; Steensgaard P; Wagener C; Sardet C; Moroni MC; Helin K
J Biol Chem; 2005 Jan; 280(2):1199-208. PubMed ID: 15536069
[TBL] [Abstract][Full Text] [Related]
29. Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo.
Sarma K; Margueron R; Ivanov A; Pirrotta V; Reinberg D
Mol Cell Biol; 2008 Apr; 28(8):2718-31. PubMed ID: 18285464
[TBL] [Abstract][Full Text] [Related]
30. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
[TBL] [Abstract][Full Text] [Related]
31. Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma.
Yonemitsu Y; Imazeki F; Chiba T; Fukai K; Nagai Y; Miyagi S; Arai M; Aoki R; Miyazaki M; Nakatani Y; Iwama A; Yokosuka O
Hum Pathol; 2009 Sep; 40(9):1304-11. PubMed ID: 19386347
[TBL] [Abstract][Full Text] [Related]
32. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
Balasubramanian S; Adhikary G; Eckert RL
Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
34. The polycomb repressive complex 2 is a potential target of SUMO modifications.
Riising EM; Boggio R; Chiocca S; Helin K; Pasini D
PLoS One; 2008 Jul; 3(7):e2704. PubMed ID: 18628979
[TBL] [Abstract][Full Text] [Related]
35. The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets.
Van Dessel N; Beke L; Görnemann J; Minnebo N; Beullens M; Tanuma N; Shima H; Van Eynde A; Bollen M
Nucleic Acids Res; 2010 Nov; 38(21):7500-12. PubMed ID: 20671031
[TBL] [Abstract][Full Text] [Related]
36. SIRT1 affects DNA methylation of polycomb group protein target genes, a hotspot of the epigenetic shift observed in ageing.
Wakeling LA; Ions LJ; Escolme SM; Cockell SJ; Su T; Dey M; Hampton EV; Jenkins G; Wainwright LJ; McKay JA; Ford D
Hum Genomics; 2015 Jun; 9(1):14. PubMed ID: 26104761
[TBL] [Abstract][Full Text] [Related]
37. Expression of EZH2 in renal cell carcinoma as a novel prognostic marker.
Lee HW; Choe M
Pathol Int; 2012 Nov; 62(11):735-41. PubMed ID: 23121604
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.
Bracken AP; Dietrich N; Pasini D; Hansen KH; Helin K
Genes Dev; 2006 May; 20(9):1123-36. PubMed ID: 16618801
[TBL] [Abstract][Full Text] [Related]
39. EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder.
Hinz S; Kempkensteffen C; Weikert S; Schostak M; Schrader M; Miller K; Christoph F
Tumour Biol; 2007; 28(3):151-7. PubMed ID: 17541304
[TBL] [Abstract][Full Text] [Related]
40. Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells.
Hussain M; Rao M; Humphries AE; Hong JA; Liu F; Yang M; Caragacianu D; Schrump DS
Cancer Res; 2009 Apr; 69(8):3570-8. PubMed ID: 19351856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
